This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Anupam Trehan: Innovator in Antimalarial Dosage Forms
Introduction
Anupam Trehan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable dosage forms for antimalarial medications. His work is crucial in the ongoing fight against malaria, a disease that continues to affect millions worldwide.
Latest Patents
Anupam Trehan holds 1 patent for his invention titled "Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials." This patent focuses on stable dosage forms that comprise spiro or dispiro 1,2,4-trioxolane antimalarials, along with their pharmaceutically acceptable salts, prodrugs, and analogues. The invention emphasizes that the water content of the dosage form should not exceed 6.5% w/w, ensuring the stability and efficacy of the medication.
Career Highlights
Anupam Trehan is currently associated with Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug formulation and development, contributing to innovative solutions in healthcare.
Collaborations
Throughout his career, Anupam has collaborated with several professionals in the field. Notable coworkers include Arno Appavoo Enose and Harish Kumar Madan, who have worked alongside him in various projects aimed at enhancing pharmaceutical formulations.
Conclusion
Anupam Trehan's contributions to the field of antimalarial dosage forms highlight his commitment to improving healthcare solutions. His innovative work continues to pave the way for advancements in pharmaceutical science.